Literature DB >> 31166102

When should we use urodynamic testing? Recommendations of the Italian Society of Urodynamics (SIUD). Part 2 - Male and neurogical population.

Andrea Braga1, Maurizio Serati2, Ester Illiano3, Francesca Manassero4, Martina Milanesi5, Franca Natale6, Marco Torella7, Donatella Pistolesi4, Cosimo De Nunzio8, Marco Soligo9, Enrico Finazzi Agrò10.   

Abstract

Recent studies in literature, have raised some doubts on the routine use of urodynamic testing. Many physicians and articles recommend a selective use of this tool, considering carefully risks and benefits. These recommendations are intended to guide clinicians in the right selection of the male and neurological patients to submit to a urodynamic evaluation. This is the second part of a previous article regarding the urodynamic recommendations in the female population. We reviewed the literature, regarding the use of UDS in male and neurological population with lower urinary tract symptoms (LUTS). Specifically, we analyzed and compared the guidelines and recommendations of the most important urology and urogynecology international scientific societies. These publications were used to create the evidence basis for characterizing the recommendations to perform urodynamic testing. A panel of 10 experts was composed and Delphi process was followed to obtain the panelist consensus. The final recommendations were approved by the unanimous consensus of the panel and compared with the best practice recommendations available in the literature. The recommendations are provided for diagnosis and management of common LUTS in male and neurological population. This review provides a summary of the most effective utilization of urodynamic studies for the global evaluation of patients with LUTS, and how to use them when really needed, avoiding unnecessary costs and patient inconveniences.

Entities:  

Mesh:

Year:  2019        PMID: 31166102     DOI: 10.23736/S0393-2249.19.03447-7

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  2 in total

1.  Artifacts and abnormal findings may limit the use of asymptomatic volunteers as controls for studies of multichannel urodynamics.

Authors:  Natalie R Swavely; John E Speich; Adam P Klausner
Journal:  Minerva Urol Nephrol       Date:  2020-07-07

Review 2.  Acceptability and perceived value of urodynamics from the patient perspective: A narrative review.

Authors:  Maurizio Serati; Andrea Braga; Peter F W M Rosier; Stefan de Wachter; Alan Uren; Enrico Finazzi-Agrò
Journal:  Neurourol Urodyn       Date:  2022-04-14       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.